PET/CT to Identify "Vulnerable" Arterial Plaque

Rambam Health Care Campus800 enrolled

Overview

The purpose of this research is to evaluate the presence, location and intensity of FDG uptake in the large arteries using the new technology of fused PET/CT imaging and to compare FDG uptake with the presence of arterial calcifications as seen on the simultaneously acquired CT, in order to determine if FDG was increases incalcified plaque or in a different location in the arterial wall. we will also evaluate the relationship between FDG localization and future cardiovascular events in out patient population

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Enrollment

800

Conditions

Cancer

Interventions

PET/CT imagingDEVICE

Eligibility

Sex: ALLMin age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients referred for clinical FDG-PET/CT studies * Patients 50 yr or older * Patients signed informed consent Exclusion Criteria: * Patients unable or unwilling to tolerate the scan until its completion

Locations (1)

Rambam Medical Center

Haifa, Israel

RECRUITING

Outcomes

Primary Outcomes

the impact of the imaging modality on patient management

Secondary Outcomes

the impact of the imaging modality on patient management

Central Contacts

Ora Israel, MD

CONTACT

972-4-8543009 o_israel@rambam.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.